Results 211 to 220 of about 393,600 (259)

Quadrivalent Conjugate Vaccine and Invasive Meningococcal Disease in US Adolescents and Young Adults.

JAMA Netw Open
Shin T, Wells CR, Shoukat A, Potter-Schwartz L, Langevin E, Langley JM, Galvani AP, Moghadas SM.   +7 more
europepmc   +1 more source

Evaluating the Efficacy of a Serious Game to Deliver Health Education About Invasive Meningococcal Disease: Clustered Randomized Controlled Equivalence Trial.

JMIR Serious Games
Bloomfield L, Boston J, Masek M, Andrew L, Barwood D, Devine A.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Invasive meningococcal disease in Chile seven years after ACWY conjugate vaccine introduction.

Vaccine, 2022
BACKGROUND A serogroup W (MenW) outbreak in Chile prompted a meningococcal vaccination campaign using tetravalent meningococcal-conjugate vaccines (MCV-ACWY) in children since 2012, followed by its introduction into the National Immunization Program (NIP)
R. Villena, M. T. Valenzuela, M. Bastías, M. Santolaya   +3 more
semanticscholar   +1 more source

Invasive Pneumococcal and Meningococcal Disease

Infectious Disease Clinics of North America, 2019
This review focuses on current knowledge of the epidemiology, prevention, and treatment of invasive pneumococcal (IPD) and meningococcal disease (IMD). IPD decreased significantly with the introduction of effective conjugate vaccines but is on the rise again.
Deirdre, Fitzgerald, Grant W, Waterer
openaire   +2 more sources

Global epidemiology and changing clinical presentations of invasive meningococcal disease: a narrative review

Infectious Diseases, 2021
Neisseria meningitidis (the meningococcus) causes significant morbidity and mortality worldwide through an epidemic or sporadic invasive infections. The epidemiology of N. meningitidis is changing and unpredictable.
A. Deghmane, Samy Taha, M. Taha
semanticscholar   +1 more source

Comorbidity increases the risk of invasive meningococcal disease in adults.

Clinical Infectious Diseases, 2021
BACKGROUND Risk of invasive meningococcal disease (IMD) is increased in patients with complement deficiency and HIV infection. Risk associated with comorbidity is not well described. METHODS Nationwide adult case-control study.
L. F. Lundbo, Z. Harboe, Håkon Sandholdt, L. Smith-Hansen, P. Valentiner-Branth, S. Hoffmann, T. Benfield   +6 more
semanticscholar   +1 more source

Current methods in the diagnosis of invasive meningococcal disease

Frontiers in Pediatrics
Invasive meningococcal disease (IMD) remains a significant health concern due to its global distribution, potential for epidemic spread, unpredictable nature, rapid progression, and high mortality rates or permanent sequelae.
E. Çiftçi, Duygu Ocal, A. Somer, Hasan Tezer, Dilek Yilmaz, Sirac Bozkurt, Oldac U Dursun, Şeyhmus Merter, E. Dinleyici   +8 more
semanticscholar   +1 more source

Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis.

Vaccine, 2019
INTRODUCTION Invasive meningococcal disease (IMD) is uncommon but still causes considerable public health burden due to its high mortality and morbidity.
B. Wang, Renee Santoreneos, L. Giles, H. Haji Ali Afzali, H. Marshall   +4 more
semanticscholar   +1 more source